# CervoMed Inc.: Form 10-Q for the period ended Sep 30, 2025

- Company: [CervoMed Inc.](/companies/crvo.md) (CIK 1053691)
- Form: 10-Q
- Filed: 2025-11-07
- Accepted by EDGAR: Nov 7, 2025, 16:47 ET
- Period: 2025-09-30
- Accession: 0001437749-25-033879
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1053691/000143774925033879/crvo20250930_10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1053691/000143774925033879/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2025-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2025-07-01 to 2025-09-30 | $322.6k | us-gaap:Revenues |
| Revenue | 9 months, 2025-01-01 to 2025-09-30 | $4.0m | us-gaap:Revenues |
| Research and development | 3 months, 2025-07-01 to 2025-09-30 | $6.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months, 2025-01-01 to 2025-09-30 | $16.0m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months, 2025-07-01 to 2025-09-30 | −$8.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2025-01-01 to 2025-09-30 | −$20.0m | us-gaap:OperatingIncomeLoss |
| Net income | 3 months, 2025-07-01 to 2025-09-30 | −$7.7m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2025-01-01 to 2025-09-30 | −$18.9m | us-gaap:NetIncomeLoss |
| Basic EPS | 3 months, 2025-07-01 to 2025-09-30 | −$0.84 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2025-01-01 to 2025-09-30 | −$2.10 | us-gaap:EarningsPerShareBasic |
| Operating cash flow | 9 months, 2025-01-01 to 2025-09-30 | −$16.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | at 2025-09-30 | $9.4m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2025-09-30 | $30.6m | us-gaap:AssetsCurrent |
| Total assets | at 2025-09-30 | $30.6m | us-gaap:Assets |
| Total liabilities | at 2025-09-30 | $4.6m | us-gaap:Liabilities |
| Shareholders' equity | at 2025-09-30 | $26.0m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1053691/000143774925033879/crvo20250930_10q.htm

Filed Nov 7, 2025.
Source: SEC EDGAR, the filing index for accession 0001437749-25-033879. Last ingested by Listed: Oct 29, 2026, 16:21 ET. No prices; not investment advice.